Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mike P Wattjes

Showing results (1-10 of 228) with videos related to

Pageof 23
Sort By:
International Psychogeriatrics|July 7, 2011
Structural MRIMike P Wattjes
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2014
Left atrial myxoma presenting with white matter lesions suggestive of multiple sclerosis: the differential diagnosis goes beyond MRIMike P Wattjes
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2017
High-frequency MRI monitoring should be performed in natalizumab-treated MS patients with higher risk of PML - CommentaryMike P Wattjes, Clemens Warnke
Annals of Neurology|January 21, 2014
Progressive multifocal leukoencephalopathy after natalizumab discontinuation: few and true?Mike P Wattjes, Joep Killestein
Neuroradiology|March 12, 2009
High field MRI in the diagnosis of multiple sclerosis: high field-high yield?Mike P Wattjes, Frederik Barkhof
Journal of Neurology, Neurosurgery, and Psychiatry|October 24, 2015
Guidelines on PML risk stratification and diagnosis in patients with MS treated with natalizumab: so far so good?Mike P Wattjes, Clemens Warnke
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 10, 2015
Low JC virus antibody index during natalizumab treatment less safe than assumed?Joep Killestein, Mike P Wattjes
Neurology|September 30, 2018
Venoplasty in MS: Therapeutic intervention without any evidenceFriedemann Paul, Mike P Wattjes
Nature Reviews. Neurology|November 13, 2013
Multiple sclerosis: CCSVI deconstructed and discardedFrederik Barkhof, Mike P Wattjes
Neuroimaging Clinics of North America|April 11, 2017
Brain and Spinal Cord MR Imaging Features in Multiple Sclerosis and VariantsIris Dekker, Mike P Wattjes
Pageof 23

Showing results (1-10 of 228) with videos related to

Sort By:
Pageof 23
International Psychogeriatrics|July 7, 2011
Structural MRIMike P Wattjes
Multiple Sclerosis (Houndmills, Basingstoke, England)|July 30, 2014
Left atrial myxoma presenting with white matter lesions suggestive of multiple sclerosis: the differential diagnosis goes beyond MRIMike P Wattjes
Multiple Sclerosis (Houndmills, Basingstoke, England)|March 14, 2017
High-frequency MRI monitoring should be performed in natalizumab-treated MS patients with higher risk of PML - CommentaryMike P Wattjes, Clemens Warnke
Annals of Neurology|January 21, 2014
Progressive multifocal leukoencephalopathy after natalizumab discontinuation: few and true?Mike P Wattjes, Joep Killestein
Neuroradiology|March 12, 2009
High field MRI in the diagnosis of multiple sclerosis: high field-high yield?Mike P Wattjes, Frederik Barkhof
Journal of Neurology, Neurosurgery, and Psychiatry|October 24, 2015
Guidelines on PML risk stratification and diagnosis in patients with MS treated with natalizumab: so far so good?Mike P Wattjes, Clemens Warnke
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 10, 2015
Low JC virus antibody index during natalizumab treatment less safe than assumed?Joep Killestein, Mike P Wattjes
Neurology|September 30, 2018
Venoplasty in MS: Therapeutic intervention without any evidenceFriedemann Paul, Mike P Wattjes
Nature Reviews. Neurology|November 13, 2013
Multiple sclerosis: CCSVI deconstructed and discardedFrederik Barkhof, Mike P Wattjes
Neuroimaging Clinics of North America|April 11, 2017
Brain and Spinal Cord MR Imaging Features in Multiple Sclerosis and VariantsIris Dekker, Mike P Wattjes
Pageof 23